fda announcement semaglutide Big news from the last week: Wegovy (semaglutide) was approved for a new use, other than weight loss semaglutide fda shortage As of

If a clinic is prescribing medication through a doctor, its easy to assume the proper credentials are in place

Melanotan 1 (afamelanotide) has been studied mainly for pigmentation disorders and photoprotection

Association of lower liver function with cognitive impairment in the Shenzhen ageing-related disorder cohort in China

Semaglutide: Single-Receptor Approach Semaglutide activates the GLP-1 receptor, producing the following effects: Appetite suppression through direct action on hypothalamic neurons that control hunger signaling Delayed gastric emptying that promotes prolonged feelings of fullness after meals Enhanced glucose-dependent insulin secretion from pancreatic beta cells Reduced glucagon secretion (different from glucagon receptor activation) that lowers hepatic glucose output Potential neuroprotective effects currently being studied in Alzheimers disease trials Research by Blundell et al

This discovery revealed kisspeptin as the master switch controlling reproductive development and function